Assembly Biosciences, Inc. Diluted Shares Outstanding (Weighted Average)
Assembly Biosciences, Inc. (ASMB) reported Diluted Shares Outstanding (Weighted Average) of 18.85 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 18.85M shares, a 146.26% increase year-over-year.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 16.90M shares, a 125.15% increase year-over-year.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 16.94M shares, a 159.20% increase year-over-year.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 12.69M shares, a 99.74% increase year-over-year.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 11.21M shares, a 86.71% increase from fiscal 2024.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 6.00M shares, a 31.18% increase from fiscal 2023.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 4.58M shares, a 13.47% increase from fiscal 2022.
- Assembly Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 4.03M shares, a 90.68% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 18.85M shares 10-Q · filed 2026-08-13 | 17.88M shares 10-Q · filed 2026-08-13 | 17.56M shares derived: average of 3 quarters · filed 2026-08-13 | 16.34M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 16.90M shares 10-Q · filed 2026-05-07 | 16.92M shares derived: average of 2 quarters · filed 2026-05-07 | 15.51M shares derived: average of 3 quarters · filed 2026-05-07 | 13.55M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 16.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 14.81M shares derived: average of 2 quarters · filed 2026-03-19 | 12.43M shares derived: average of 3 quarters · filed 2026-08-13 | 11.21M shares 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | 12.69M shares 10-Q · filed 2025-11-10 | 10.17M shares derived: average of 2 quarters · filed 2026-08-13 | 9.30M shares 10-Q · filed 2025-11-10 | 8.60M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 7.66M shares 10-Q · filed 2026-08-13 | 7.58M shares 10-Q · filed 2026-08-13 | 7.23M shares derived: average of 3 quarters · filed 2026-08-13 | 7.01M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 7.51M shares 10-Q · filed 2026-05-07 | 7.02M shares derived: average of 2 quarters · filed 2026-05-07 | 6.80M shares derived: average of 3 quarters · filed 2026-05-07 | 6.51M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 6.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 6.44M shares derived: average of 2 quarters · filed 2026-03-19 | 6.18M shares derived: average of 3 quarters · filed 2026-03-19 | 6.00M shares 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | 6.35M shares 10-Q · filed 2025-11-10 | 6.00M shares derived: average of 2 quarters · filed 2025-11-10 | 5.83M shares 10-Q · filed 2025-11-10 | 5.70M shares derived: average of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | 5.64M shares 10-Q · filed 2025-08-06 | 5.56M shares 10-Q · filed 2025-08-06 | 5.48M shares derived: average of 3 quarters · filed 2025-08-06 | 5.21M shares derived: average of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | 5.48M shares 10-Q · filed 2025-05-08 | 5.40M shares derived: average of 2 quarters · filed 2025-05-08 | 5.06M shares derived: average of 3 quarters · filed 2025-05-08 | 4.89M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 5.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 4.85M shares derived: average of 2 quarters · filed 2025-03-20 | 4.69M shares derived: average of 3 quarters · filed 2025-03-20 | 4.58M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 4.38M shares 10-Q · filed 2024-11-07 | 52.57M shares 10-Q · filed 2023-11-08 | 4.37M shares derived: average of 2 quarters · filed 2024-11-07 | 4.33M shares 10-Q · filed 2024-11-07 | 51.95M shares 10-Q · filed 2023-11-08 | -28.94M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 4.36M shares 10-Q · filed 2024-08-08 | 52.26M shares 10-Q · filed 2023-08-09 | 4.30M shares 10-Q · filed 2024-08-08 | 51.64M shares 10-Q · filed 2023-08-09 | -40.04M shares derived: average of 3 quarters · filed 2024-08-08 | -17.92M shares derived: average of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | 4.25M shares 10-Q · filed 2024-05-08 | 51.01M shares 10-Q · filed 2023-05-04 | -62.24M shares derived: average of 2 quarters · filed 2024-05-08 | -25.34M shares derived: average of 3 quarters · filed 2024-05-08 | -6.93M shares derived: average of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | -128.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -40.14M shares derived: average of 2 quarters · filed 2024-03-28 | -10.66M shares derived: average of 3 quarters · filed 2024-03-28 | 4.03M shares 10-K · filed 2024-03-28 | 48.41M shares 10-K · filed 2023-03-22 | |||
| 2022-09-30 | 48.45M shares 10-Q · filed 2023-11-08 | 48.37M shares derived: average of 2 quarters · filed 2023-11-08 | 48.29M shares 10-Q · filed 2023-11-08 | 47.45M shares derived: average of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | 48.29M shares 10-Q · filed 2023-08-09 | 48.21M shares 10-Q · filed 2023-08-09 | 47.12M shares derived: average of 3 quarters · filed 2023-08-09 | 46.73M shares derived: average of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | 48.12M shares 10-Q · filed 2023-05-04 | 46.54M shares derived: average of 2 quarters · filed 2023-05-04 | 46.21M shares derived: average of 3 quarters · filed 2023-05-04 | 45.38M shares derived: average of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | 44.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 45.26M shares derived: average of 2 quarters · filed 2023-03-22 | 44.46M shares derived: average of 3 quarters · filed 2023-03-22 | 43.28M shares 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 45.57M shares 10-Q · filed 2022-11-08 | 44.22M shares derived: average of 2 quarters · filed 2022-11-08 | 42.73M shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 42.88M shares 10-Q · filed 2022-08-09 | 41.29M shares 10-Q · filed 2022-08-09 | ||||||
| 2020-06-30 | 37.29M shares 10-Q · filed 2021-08-05 | 35.23M shares 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | 35.08B shares 10-Q · filed 2020-05-08 | |||||||
| 2019-09-30 | 25.91M shares 10-Q · filed 2019-11-07 | 25.83M shares derived: average of 2 quarters · filed 2020-08-05 | 25.77M shares 10-Q · filed 2019-11-07 | |||||
| 2019-06-30 | 25.74M shares 10-Q · filed 2020-08-05 | 25.69M shares 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | 25.67B shares 10-Q · filed 2020-05-08 | 25.67M shares 10-Q · filed 2019-05-09 | ||||||
| 2018-09-30 | 24.88M shares 10-Q · filed 2019-11-07 | 22.71M shares derived: average of 2 quarters · filed 2019-11-07 | 21.90M shares 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | 20.54M shares 10-Q · filed 2019-08-05 | 20.39M shares 10-Q · filed 2019-08-05 | ||||||
| 2018-03-31 | 20.23M shares 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |